From Cato Today <[email protected]>
Subject The Economics of Lockdowns
Date April 8, 2020 11:12 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Tune into an online event about the economics of lockdowns. The FDA hasn't prohibited the prescription of chloroquine against COVID-19.

View in browser ([link removed] )

April 8, 2020

LIVE ONLINE EVENT

The Economics of Lockdowns ([link removed] )

Thursday • April 9, 2020 • 12:00PM-1:15PM

covid-19-economy ([link removed] )

The COVID-19 pandemic has had dire effects on both public health and the economy. In reaction to the virus’s spread, many states have implemented stay‐​at‐​home orders and closures of all “nonessential businesses.” National lockdowns have been mandated all over Europe.

Join this panel of experts for an online event that answers a broad range of questions about economic implications of such a widespread lockdown.

FEATURING:

- John Cochrane, Senior Fellow at the Hoover Institution, Stanford University, Adjunct Scholar at the Cato Institute
- Anna Scherbina, Associate Professor of Finance, Brandeis University
- Emil Verner, Assistant Professor of Finance, Massachusetts Institute of Technology
- Simon Mongey, Assistant Professor of Economics, University of Chicago

Moderated by Ryan Bourne, R. Evan Scharf Chair for the Public Understanding of Economics, Cato Institute.

- LIVE ONLINE: The Economics of Lockdowns ([link removed] )

Thursday • April 9, 2020 • 12:00PM-1:15PM

REGISTER ([link removed] )

COMMENTARY

202003_coronavirus_test ([link removed] )

An Economist’s Perspective on COVID-19 ([link removed] )

Economists aren’t queasy about undertaking cost‐​benefit analyses of shutdowns, though they debate the assumptions used.

- On Coronavirus, Economists Think Differently from the 'Common Sense' Crowd ([link removed] )

By Ryan Bourne

Doctor ([link removed] )

Doctors Can Prescribe Chloroquine Against the Coronavirus ([link removed] )

Chloroquine, hydoxychloroquine, and other drugs haven't gone through the FDA approval process for treatment against Coronavirus yet. It is important, however, for people to know that clinicians are not prohibited from prescribing these drugs now.

- No, the FDA Can't Stop Doctors from Prescribing Chloroquine ([link removed] )

By Jeffrey A. Singer

Sign Up For Other Cato Newsletters ([link removed] )

SUPPORT CATO ([link removed] )

Facebook ([link removed] )

LinkedIn ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

YouTube ([link removed] )

Cato Institute, 1000 Massachusetts Ave, NW, Washington, DC 20001, (202) 842-0200

Manage preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis